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Abstract
Objectives The left atrium (LA) modulates left ventricular fill-
ing through reservoir, conduit and booster pump functions. Only
limited data exist on LA involvement in type 2 diabetes mellitus
(DM2). This study sought to assess LA function in asymptom-
atic DM2 with cardiac MRI. We hypothesized that cardiac MRI
can detect LA dysfunction in asymptomatic DM2.
Methods Forty-five patients with asymptomatic DM2 and 24
normoglycaemic controls were studied.MRI cine imagingwas
performed to measure LA maximal and minimal volumes. A
flow-sensitive phase-contrast gradient-echo sequencewas used
for flowmeasurements perpendicular to the orifice of themitral
valve, to quantify active LA stroke volume. LA total, passive
and active emptying volumes and fractions were calculated.
Results LA reservoir function, namely LA total ejection frac-
tion, was significantly greater in controls compared to patients
with DM2 (62.2±5.2 vs 57.0±7.6 %, P=0.004). LA passive
ejection fraction was also greater in the controls (26.2±9.5 vs
16.1±11.0 %, P<0.001). Regarding parameters of LA booster
pump function, LA active ejection fraction was not
significantly different between groups. DM2 was demonstrat-
ed to be an independent determinant of LA function.
Conclusions Cardiac MRI enables the detection of LA dys-
function in asymptomatic DM2, characterized by a reduction
in LA reservoir and conduit functions.
Key Points
• Evaluation of left atrial function is feasible with cardiac MRI
• Type 2 diabetes mellitus is associated with left atrial
dysfunction
• Left atrial function modulates left ventricular filling
Keywords Cardiac imaging techniques .Magnetic resonance
imaging . Transmitral flow . Left atrial function . Diabetes
mellitus
Abbreviations
DM2 type 2 diabetes mellitus
LA left atrium
LAEF left atrial ejection fraction
LAmax left atrial maximal volume
LAmin left atrial minimal volume
LApreA left atrial volume pre-atrial contraction
LASV left atrial stroke volume
LV left ventricle
TMF transmitral flow
VENC velocity encoded
Introduction
Patients with type 2 diabetes (DM2) have an increased risk of
developing cardiovascular disease, resulting in significant
cardiac morbidity and mortality [1]. In DM2 morphological
changes suggestive of heart disease may appear before
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symptoms arise and the prevalence of subclinical left ventric-
ular (LV) dysfunction is increased among these patients [2].
Several mechanisms may underlie LV dysfunction in
DM2, including atherosclerosis, microinfarctions, mitochon-
drial dysfunction, lipotoxicity and accumulation of advanced
glycation end products, leading to myocyte hypertrophy,
perivascular fibrosis and increased quantities of matrix colla-
gen [3]. All suggested mechanisms leading to LV dysfunction
in DM2 include systemic phenomena that can also impact the
function of the left atrium (LA).
Left atrial function has been conventionally divided into three
phases across the different phases of the cardiac cycle. First,
during ventricular systole and isovolumetric relaxation, the LA
acts as a reservoir and stores pulmonary venous return. Then,
during ventricular diastole, LA emptying consists of two distinct
components in subjects with sinus rhythm: the early component
is related to passive blood flow from the LA, the pulmonary
veins and the LA appendage into the LV; and the late component
is related to active LA contraction and is referred to as the LA
booster function for LV filling [4]. Through these varying
mechanical functions, the LA modulates LV filling and plays a
key role in maintaining an optimal cardiac performance.
LAvolume and function are robust markers of cardiovascular
risk and adverse cardiac outcome across a broad range of car-
diovascular pathologies [5–7]. A recent prospective observation-
al follow-up study of DM2 patients without overt cardiovascular
disease demonstrated that a dilated LAwas a predictor of death
and major cardiovascular events [8]. Regarding LA function, its
prognostic importance in diabetes has not been evaluated.
Fundamental structural and functional properties of the left
atrium are often assessed in the clinical setting using 2D
echocardiography.
Cardiac MRI offers several inherent advantages for the as-
sessment of LA size and function owing to its high spatial
resolution, superior endocardial border definition, and capacity
for unrestricted multiplanar imaging, independent of acoustic
windows that may limit echocardiography [9]. Basic measure-
ments of LA size and function can be achievedwith cardiacMRI
by using the images routinely taken for LV function assessment.
There are limited published data on LA involvement in
DM2 [10, 11] and, as far as we are aware, there is no study
about the role of MRI in the evaluation of LA function in
DM2. Accordingly, the purpose of this study was to compare
cardiac MRI-derived parameters of LA function between
well-controlled uncomplicated DM2 and normoglycaemic
control subjects. Moreover, obesity and arterial hypertension
are common in the clinical setting of DM2 and could also
induce LA dysfunction.
So, we also aim to evaluate how DM2, arterial hyperten-
sion and body mass index influence LA function.
We hypothesized that asymptomatic DM2 patients will
have reduced LA function compared with normoglycaemic
control subjects.
Materials and methods
Study population
Forty-five patients with DM2were prospectively recruited from
the endocrinology department of our institution. Inclusion
criteria included age between 45 and 75 years, no symptoms
or history of overt heart disease, no signs or symptoms of
cerebrovascular disease, no abnormal findings on routine clin-
ical and physical examination and a normal rest ECG. Patients
who had a left ventricular ejection fraction less than 55 %,
regional LV wall motion abnormalities and valvular heart dis-
ease, contraindications to MRI, glomerular filtration rate less
than 30 mL/min, glycated haemoglobin greater than 12 %,
systolic blood pressure above 160mmHg and/or diastolic blood
pressure above 100 mmHg, underlying cardiomyopathy, previ-
ous myocardial infarction, coronary revascularization or previ-
ous cardiac surgery were excluded. Twenty-four healthy vol-
unteers recruited from the local population served as control
and had no history of heart disease, diabetes mellitus or high
cholesterol. They had a normal physical examination and ECG.
All subjects gave informed consent to participate in the study,
which was approved by our institutional ethics committee.
Cardiac MRI protocol
All images were acquired with electrocardiographic gating,
breath-holding and the patient in a supine position. Subjects
were imaged on a 3-T MR system (Tim Trio, Siemens,
Erlangen, Germany). The basic protocol consisted of cine
steady-state free-precession imaging (TR, 3.4 ms; TE, 1.2 ms;
in-plane spatial resolution, 1.6×2.1 mm) for LV function and
mass. Cine imaging was obtained in 8–12 matching short-axis
(8 mm thick with 2 mm gap) and three standard long-axis
planes (two-, three- and four-chamber views). For the calcula-
tion of LV mass and function, the endocardial and epicardial
borders of the LV myocardium were manually traced on suc-
cessive short-axis cine images at end-diastole and systole.
A breath-held, retrospectively vector-ECG gated, 2D flow-
sensitive phase-contrast gradient-echo sequence was used for
velocity-encoded (VENC) MRI flow measurements perpen-
dicular to the orifice of the mitral valve. VENC-MRI slices
were positioned in early diastole at the tip of the mitral valve
leaflets. Typical imaging parameters of VENC-MRI were as
follows: slice thickness, 6 mm; repetition time, 4.5 ms; echo
time, 2.33 ms; number of segments, 3; acquired temporal
resolution, 36 ms; 20° flip angle, 25 calculated phases and
pixel spacing 4.5×3.1 mm. Encoding velocity was set to
130 cm/s [12, 13]. Flow analysis was performed on the
through-plane VENC-MRI phase-contrast and magnitude im-
ages acquired across the mitral valve. To determine total blood
flow and volume, region of interest curves on the VENC-MRI
phase-contrast images were drawn in the diastole at the mitral
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valve orifice and propagated to all phases to obtain the
transmitral flow (TMF) curve [14] (Fig. 1). From the analysis
of the TMF curve, the following measurements were per-
formed: E and A mean peak velocities (in centimetres per
second), E/A ratio and mitral deceleration time (MDT) (mea-
sured from the E peak to the baseline).
Left atrial measurements
Left atrial volume measurements were performed in the four-
and two-chamber orientations by the biplane area–length
methods. In the analysis we excluded the atrial appendage
and the pulmonary veins. The parameters of LA size and
function included in our analyses were as follows:
& LA minimum volume (LAmin): LA end-diastolic volume
at the first frame after mitral valve closure (Fig. 2a, b).
& LA maximum volume (LAmax): LA end-systolic volume
right before mitral valve opening (Fig. 2c, d).
LA reservoir function
& Total LA stroke volume (LASV) = LAmax − LAmin.
& Total LA ejection fraction (LAEF) = total LASV/LAmax
LA contractile function
& Active LASV: directly obtained by VENC-MRI from
TMF curves (Fig. 3), using a MATLAB script
& LA volume pre-atrial contraction (LApreA) = LAmin +
Active LASV
& Active LAEF = active LASV/LApreA
LA conduit function
& Passive LASV = LA max − LApreA
& Passive LAEF = passive LASV/LAmax
MR image analysis
Quantitative image data analysis was performed by using
dedicated software (Segment, Medviso, Lund, Sweden) [15].
All functional evaluations were performed within 25 min per
patient.
Reproducibility
In five randomly selected studies from each group, two
readers independently measured the LAmax, LAmin and ac-
tive LASV. One observer remeasured the same 10 studies at a
separate time to determine intraobserver agreement from the
baseline studies.
Statistical analysis
All continuous variables were tested for normal distribution.
All normally distributed data are expressed as means±stan-
dard deviations. Categorical variables are expressed as counts
and percentages. Differences between means of the DM2
group and controls were examined by the unpaired t test.
Between-group differences in numbers and percentages were
compared using the Chi-squared test.
Univariate and multiple analyses with a forward selection
procedure were performed. The goal of these analyses was to
determine which factors were responsible for the difference in
LA phasic function (total LAEF and passive LAEF) between
groups. We employed a two-step strategy for the selection of
variables. The first step was that a variable had to be signifi-
cantly different between groups. If so, in univariate analysis
there had to be an association between this variable and the
dependent variable with P<0.1. The variables fulfilling these
criteria were then entered into a multivariable regression anal-
ysis and those with P<0.05 were considered independently
related to the dependent variable. Intraobserver and interob-
server variability were assessed by using a Bland–Altman
analysis. All computations were performed with software
(SPSS, version 20.0; SPSS, Chicago, IL).
Results
Demographic data and LV parameters of the DM2 group vs.
controls are presented in Table 1. Body mass index was
significantly increased in the DM2 group (P<0.001). Our
population of DM2 had a higher (53 %) prevalence of sys-
temic arterial hypertension (HT), although not significantly
greater than the control group.
All left ventricular volumes and masses were in the normal
range, with no significant difference between groups.
Fig. 1 Phase-encoded MRI image obtained with a phase-contrast se-
quence shows a region of interest placed at the mitral orifice (arrow). The
transmitral flow curve was obtained from this region of interest
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Fig. 3 The transmitral flow curve
is composed of two peaks. The
first one is the E wave and second
one is the Awave. The E wave
corresponds to rapid LV filling at
early diastole; the Awave
corresponds to late LV filling
during end-diastole, secondary to
LA contraction. Active left atrial
stroke volume was directly
obtained from the analysis of the
area under the Awave (filled in
yellow)
Fig. 2 Cine-MRI slices were
acquired in the two-chamber
(upper row) and four-chamber
(lower row) long-axis orientation.
Minimal (a, b) and maximal left
atrial (c, d) volumes were
calculated using the biplane area–
length method. The atrial
appendage and the pulmonary
veins were excluded from the
measurements
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Subjects with DM2 had significantly decreased diastolic
functional parameters with greater mitral peak A velocity and
lower mitral E/A ratio (P=0.010; P=0.002, respectively).
Intraobserver and interobserver variability of left atrial
measurements
The intraobserver limits of agreement were −2.1 mL to 0.6 mL
for LAmin, 0.5 mL to 3.9 mL for LAmax and −2.1 mL to
1.2 mL for active LASV. The interobserver limits of agree-
ment were 0.02 mL to 4.2 mL for LAmin, −3.0 mL to 2.6 mL
for LAmax and −0.9 mL to 1.2 mL for active LASV. The
corresponding intraclass correlation coefficient values were
0.99, 0.99 and 0.95 for the intraobserver analysis and 0.97,
0.98 and 0.98 for the interobserver analysis for LAmin,
LAmax and active LASV, respectively.
Left atrial measures
Indexed LA minimum and maximum volumes were not sig-
nificantly different between groups (Table 2).
A parameter of LA reservoir function, namely total
LAEF, was significantly greater in the control group
(P=0.034).
A parameter of LA conduit function, namely LA passive
ejection fraction, was also significantly greater in the control
group (P<0.001).
Regarding parameters of LA booster pump function, in-
cluding indexed LA active stroke volume and active LAEF,
values were not significantly different between groups.
Factors that influence LA function
Table 3 outlines the univariate Pearson correlations for total
and passive LAEF. There was no significant correlation
between total LAEF and age, body mass index, LV ejection
fraction, indexed LV mass, indexed end-diastolic LV volume,
mitral peak A velocity and mitral E/A ratio.
There was a significant, low to moderate negative
correlation between passive LAEF and age, body mass
index and mitral peak A velocity. There was a signifi-
cant, moderate positive correlation between passive
LAEF and mitral E/A ratio. There was no significant
correlation between passive LAEF and LV ejection frac-
tion, indexed end-diastolic LV volume and indexed LV
mass.
To identify the independent determinants of total and
passive LAEF, univariate predictors with P<0.10 were
all entered into a multiple linear regression model as
covariates (Table 4).
On multivariable analysis, total LAEF was independently
influenced and reduced in DM2 and with increased BMI.
Passive LAEF was related to E/A ratio.
Table 1 Baseline characteristics of the study population and left ventricular measurements
DM2 group (n=45) Normoglycaemic group (n=24) P value
Age, years 58.9±6.9 55.8±6.8 0.081
Male, n (%) 24/45 (53) 14/24 (58) 0.801
Body surface area, m2 1.87±0.21 1.83±0.18 0.374
Body mass index, kg/m2 29.5±4.4 25.6±3.1 <0.001
Hypertension, n (%)* 24/45 (53) 8/24 (33) 0.011
LV EDV/BSA, mL/m2 77.4±14.4 79.8±13.9 0.507
LV EF, % 61.6±7.2 64.5±5.6 0.119
LV mass / BSA, g/m2 64.6±13.1 62.4±13.4 0.529
Mitral peak E velocity, cm/s 42.3±11.9 46.4±11.6 0.168
Mitral peak A velocity, cm/s 50.3±10.7 43.9±8.9 0.010
Mitral E/A ratio 0.86±0.27 1.08±0.27 0.002
BP blood pressure, LV left ventricle, EDV end-diastolic volume, BSA body surface area, EF ejection fraction
* Blood pressure>140/90 mmHg or treatment with anti-hypertensive medication
Table 2 Left atrial measurements
DM2 group
(n=45)
Normoglycaemic
group (n=24)
P value
LAmin/BSA, mL/m2 16.7±6.9 13.9±3.9 0.096
LAmax/BSA, mL/m2 37.7±11.0 36.0±7.6 0.488
Total LASV/BSA, mL/m2 21.0±5.8 22.1±4.4 0.431
Active LASV/BSA, mL/m2 13.8±3.6 13.2±3.9 0.522
Passive LASV/BSA, mL/m2 7.2±5.6 9.0±5.5 0.243
Total LAEF, % 56.9±8.2 62.2±9.3 0.034
Passive LAEF, % 27.6±18.2 45.3±15.5 <0.001
Active LAEF, % 46.7±11.8 49.0±12.9 0.513
BSA body surface area, LAmin left atrial minimum volume, LAmax left
atrial maximum volume, LASV left atrial stroke volume, LAEF left atrial
ejection fraction
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Discussion
In this study, MRI-derived parameters of LA function in
patients with DM2 were investigated. Differences in LA
function were observed between DM2 patients and con-
trol subjects. LA phasic function is changed in asymp-
tomatic DM2, with an associated decrease in reservoir
(total LAEF) and conduit (passive LAEF) functions.
Conversely, there was no change in LA booster
function.
We have demonstrated that DM2 and body mass index are
independent determinants of LA reservoir function on multi-
variate analysis. Mitral E/A ratio is an independent determi-
nant of LA passive function.
Left atrial reservoir function
During LV systole and isovolumic relaxation, the LA func-
tions as a reservoir, receiving blood from the pulmonary veins
and storing energy in the form of pressure. This atrial function
is mainly modulated by LV contraction, through the descent of
the LV base during systole and by LA properties (i.e. relaxa-
tion and chamber stiffness) [16].
Our group of DM2 patients demonstrated lower total LA
ejection fractions compared to normoglycaemic controls. This
could by explained by a decrease in LA compliance in the
DM2 group [17] in the context of diabetic cardiomyopathy.
An impairment of LA compliance in DM2 has been recently
demonstrated by Kadappu et al. [11], by showing that echo-
cardiographic parameters of global and segmental strains of
the LAwere significantly reduced in subjects with DM2.
Left atrial conduit function
During early LV diastole, the pressure in the left atrium falls
and flow in the pulmonary veins increases. During this period,
the left atrium acts as a passive conduit (conduit function of
the left atrium) and blood is transferred into the LV through
the LAvia a small pressure gradient and flows passively from
the pulmonary veins into the LV. Traditionally the LA passive
stroke volume is not easily measured, because while the mitral
valve is open, some blood flows directly from the pulmonary
veins and LA appendage [16]. In our study, we obtained the
LA active atrial emptying volume directly by measurement of
transmitral total flow across all the area of the mitral valve,
and added this volume to LA minimum volume to establish
the LAvolume before LA contraction. The LA passive stroke
volume was obtained by subtracting this LA volume before
LA contraction to LA maximum volume. This method is not
confounded by passive diastolic blood flow from the pulmo-
nary veins and LA appendage [18]. Passive LA ejection
fraction is the proportion of the LA passive stroke volume to
LA maximum volume.
In our study DM2 patients demonstrated lower LA passive
ejection fraction compared to normal controls. The explana-
tion for this finding could reside in the LV. Left atrial passive
stroke volume is effectively drawn into the left ventricle via
LV suction, and it may be more appropriately viewed as a
property of LV diastolic function rather than intrinsic LA
function. This conduit function is modulated especially by
LV diastolic properties (LV relaxation and early diastolic
pressures) [19].
Table 3 Univariate Pearson correlation coefficients analysis of total LAEF and passive LAEF
Total LAEF Passive LAEF
Correlation Coefficient P value Correlation coefficient P value
Age 0.20 0.876 −0.30 0.017
Body mass index −0.22 0.083 −0.32 0.012
LV EDV/BSA, mL/m2 0.084 0.522 0.004 0.977
LV mass/BSA, g/m2 −0.172 0.184 −0.228 0.077
Mitral peak A velocity 0.17 0.190 −0.29 0.024
Mitral E/A ratio 0.07 0.583 0.48 <0.001
LAEF left atrial ejection fraction
Table 4 Independent determinants of total LAEF and passive LAEF
β P value
Total LAEF
Diabetes mellitus −0.15 0.017
Arterial hypertension −0.01 0.918
Body mass index 1.10 <0.001
Passive LAEF
Diabetes mellitus −0.18 0.182
Hypertension 0.04 0.670
Body mass index −0.03 0.927
Mitral peak A velocity 0.22 0.328
Mitral E/A ratio 0.89 <0.001
LAEF left atrial ejection fraction
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DM2-related changes in LV diastolic properties are well
recognized with a decrease in early diastolic filling, directly
influenced by abnormal LV relaxation, and an increased pas-
sive stiffness due to remodelling [20]. In fact, the DM2 group
of our study showed higher mitral peak A velocity and lower
mitral E/A ratio compared to normal controls. Also, mitral
E/A ratio was an independent determinant of LA conduit
function. Higher mitral peak A velocity and lower mitral
E/A ratio are markers of impaired LV relaxation [21], suggest-
ing that there may be a link between LV diastolic properties
and LA function.
Left booster pump function
In the presence of a sinus rhythm, LV filling is completed by
atrial contraction. The LA is a contractile chamber that active-
ly empties immediately before the onset of LV systole and
establishes final LV end-diastolic volume. LA booster pump
function is mostly dependent on intrinsic atrial contractility
and becomes increasingly important to the preservation of
cardiovascular performance in the presence of reduced LV
compliance [16].
In our study, the parameters of LA booster pump function
(active LA stroke volume and active LA ejection fraction)
were similar in both groups.
Muranaka et al. [10] also showed a reduction in atrial
phasic function in diabetes mellitus, as measured by strain
rate parameters. Their results also point to an impairment of
LA reservoir and conduit functions in patients with DM2 [10].
Asbun and Villarreal [17] demonstrated a relation between
diabetic cardiomyopathy and a reduction in LA compliance. A
recent study from van Schinkel et al. [22] also demonstrated
an association of type 1 diabetes mellitus, aortic stiffness
(determined by MRI-assessed pulse wave velocity) and de-
crease in LA compliance (measured with echocardiographic
speckle tracking strain analysis). Kadappu et al. [11] evaluated
LA function by strain and strain rate derived from 2D speckle
tracking in patients with DM2. Patients with DM2 had altered
phasic LA function with impaired LA reservoir, conduit and
contractile functions [11].
The findings of our study contribute to the available knowl-
edge, favouring the hypothesis that there is a relationship
between DM2, obesity and left atrial dysfunction.
The originality of our study is the use of cardiac MRI-
derived parameters of LA function.
While MRI represents the current gold standard for assess-
ment of LA size and function [23], there are limited data
available on this topic.
Traditionally, LA size and function has been studied by
performing 2D echocardiography. However, cyclic changes of
LAvolume may not be observed directly by 2D echocardiog-
raphy because the shape of the LA changes during the heart
cycle, and the pattern is influenced by the loading conditions
[24]. Therefore, 2D echocardiography presents only a snap-
shot view of the LA function.
In contrast, MRI data acquisition is distributed across sev-
eral cardiac cycles in segmented ECG-gated sequences. Thus,
cardiac MRI has been proved to be an effective alternative for
accurately assessing the LAvolume and phasic function [25].
There is growing evidence that LA size and function serves
as an important diagnostic and prognostic factor in a variety of
conditions, including DM2 [8]. Therefore, comprehensive
evaluation of LA function might be an important clinical
factor to stratify the risk of preclinical cardiovascular disease
and could be integrated into a routine cardiac MRI protocol
for the evaluation of high-risk subjects, including patients with
DM2.
There are a few limitations to our study. This study was a
case-control study with a relatively small number of subjects
and our findings need to be validated in a larger population.
Our findings are limited by an inability to eliminate causal
relationships with important clinical factors, such as medica-
tions used, serum concentrations of glucose, and glycosylated
haemoglobin, dyslipidaemia, retinopathy, microabuminuria
and smoking status.
The possibility of influence of myocardial ischaemia or
fibrosis on LVor LA function cannot be completely excluded.
Although stress imaging is recommended for symptomatic
type 2 diabetics, there is still no consensus on the best ap-
proach for screening asymptomatic diabetic subjects without
known coronary artery disease [26]. In the absence of suffi-
cient clinical indication, it was not deemed ethical to subject
these asymptomatic subjects to gadolinium myocardial perfu-
sion and delayed enhancement.
For the analysis of the LA volumes, a true volumetric
approach, such as the use of a contiguous short-axis stack, is
preferred. However, the biplane area–length method is a val-
idated good compromise between accuracy and speed, as it
does not require extra image acquisition apart from that rou-
tinely taken for LV function assessment [27].
This study highlights certain key points for the routine use
of cardiacMRI to study LA function in diabetic patients. First,
evaluation of LA function is feasible with cardiac MRI.
Second, body mass index and diabetes independently influ-
ence LA function. Third, cardiac MRI shows a decrease in LA
reservoir and conduit functions in DM2 and may allow the
diagnosis of subclinical LA dysfunction in this high-risk
population.
Acknowledgments The scientific guarantor of this publication is Filipe
Caseiro-Alves. The authors of this manuscript declare no relationships
with any companies whose products or services may be related to the
subject matter of the article. This study has received funding under project
“DoIT”, co-financed by the European Community Fund FEDER through
COMPETE – Programa Operacional Factores de Competitividade.
Miguel Patrício kindly provided statistical advice for this manuscript.
Eur Radiol (2014) 24:2669–2676 2675
Institutional review board approval was obtained. Written informed con-
sent was obtained from all subjects (patients) in this study. Methodology:
prospective, case-control study, performed at one institution.
References
1. Haffner SM, Lehto S, Rönnemaa T et al (1998) Mortality from
coronary heart disease in subjects with type 2 diabetes and in nondi-
abetic subjects with andwithout prior myocardial infarction. N Engl J
Med 339:229–234
2. Boyer JK, Thanigaraj S, Schechtman KB, Pérez JE (2004)
Prevalence of ventricular diastolic dysfunction in asymptomatic,
normotensive patients with diabetes mellitus. Am J Cardiol 93:
870–875
3. Devereux RB, Roman MJ, Paranicas M et al (2000) Impact of
diabetes on cardiac structure and function: the strong heart study.
Circulation 101:2271–2276
4. Barbier P, Solomon SB, Schiller NB, Glantz SA (1999) Left atrial
relaxation and left ventricular systolic function determine left atrial
reservoir function. Circulation 100:427–436
5. Tsang MY, Barnes ME, Tsang TS (2012) Left atrial volume: clinical
value revisited. Curr Cardiol Rep 14:374–380
6. Viera MJ, Teixeira R, Gonçalves L, Gersh BJ (2014) Left atrial
mechanics: echocardiographic assessment and clinical implications.
J Am Soc Echocardiogr 27:463–478
7. Hoit BD (2014) Left atrial size and function: role in prognosis. J Am
Coll Cardiol 63:493–505
8. Poulsen MK, Dahl JS, Henriksen JE et al (2013) Left atrial volume
index: relation to long-term clinical outcome in type 2 diabetes. J Am
Coll Cardiol 62:2416–2421
9. Anderson JL, Horne BD, Pennell DJ (2005) Atrial dimensions in
health and left ventricular disease using cardiovascular magnetic
resonance. J Cardiovasc Magn Reson 7:671–675
10. Muranaka A, Yuda S, Tsuchihashi K et al (2009) Quantitative as-
sessment of left ventricular and left atrial functions by strain rate
imaging in diabetic patients with and without hypertension.
Echocardiography 26:262–271
11. Kadappu KK, Boyd A, Eshoo S et al (2012) Changes in left atrial
volume in diabetes mellitus: more than diastolic dysfunction? Eur
Heart J Cardiovasc Imaging 13:1016–1023
12. Caudron J, Fares J, Bauer F, Dacher JN (2011) Evaluation of left
ventricular diastolic function with cardiac MR imaging.
Radiographics 31:239–259
13. Duarte R, Fernandez G (2010) Assessment of left ventricular diastol-
ic function byMR: why, how and when. Insights Imaging 1:183–192
14. Marsan NA, Westenberg JJ, Ypenburg C et al (2009) Quantification
of functional mitral regurgitation by real-time 3D echocardiography:
comparison with 3D velocity-encoded cardiac magnetic resonance.
JACC Cardiovasc Imaging 2:1245–1252
15. Heiberg E, Sjögren J, Ugander M et al (2010) Design and validation
of segment–freely available software for cardiovascular image anal-
ysis. BMC Med Imaging 10:1
16. Rosca M, Lancellotti P, Popescu BA, Piérard LA (2011) Left atrial
function: pathophysiology, echocardiographic assessment, and clini-
cal applications. Heart 97:1982–1989
17. Asbun J, Villarreal FJ (2006) The pathogenesis of myocardial fibrosis
in the setting of diabetic cardiomyopathy. J AmColl Cardiol 47:693–
700
18. Muellerleile K, GrothM, SaringD et al (2012) Evaluation of different
magnetic resonance imaging techniques for the assessment of active
left atrial emptying. Eur Radiol 22:1904–1911
19. Bowman AW, Kovács SJ (2004) Left atrial conduit volume is gener-
ated by deviation from the constant-volume state of the left heart: a
combined MRI-echocardiographic study. Am J Physiol Heart Circ
Physiol 286:H2416–H2424
20. von Bibra H, St John Sutton M (2010) Diastolic dysfunction in
diabetes and the metabolic syndrome: promising potential for diag-
nosis and prognosis. Diabetologia 53:1033–1045
21. Nagueh SF, Appleton CP, Gil lebert TC et al (2009)
Recommendations for the evaluation of left ventricular diastolic
function by echocardiography. Eur J Echocardiogr 10:165–193
22. Van Schinkel LD, Auger D, van Elderen SG et al (2013) Aortic
stiffness is related to left ventricular diastolic function in patients with
diabetes mellitus type 1: assessment with MRI and speckle tracking
strain analysis. Int J Cardiovasc Imaging 29:633–641
23. Järvinen V, Kupari M, Hekali P, Poutanen VP (1994) Assessment of
left atrial volumes and phasic function using cine magnetic resonance
imaging in normal subjects. Am J Cardiol 73:1135–1138
24. Cameli M, Lisi M, Righini FM, Mondillo S (2012) Novel echocar-
diographic techniques to assess left atrial size, anatomy and function.
Cardiovasc Ultrasound 10:4
25. Hudsmith LE, Petersen SE, Francis JM et al (2005) Normal human
left and right ventricular and left atrial dimensions using steady state
free precession magnetic resonance imaging. J Cardiovasc Magn
Reson 7:775–782
26. Anand DV, Lim E, Hopkins D et al (2006) Risk stratification in
uncomplicated type 2 diabetes: prospective evaluation of the com-
bined use of coronary artery calcium imaging and selective myocar-
dial perfusion scintigraphy. Eur Heart J 27:713–721
27. Sievers B, Kirchberg S, AddoM et al (2004) Assessment of left atrial
volumes in sinus rhythm and atrial fibrillation using the biplane area-
length method and cardiovascular magnetic resonance imaging with
TrueFISP. J Cardiovasc Magn Reson 6:855–863
2676 Eur Radiol (2014) 24:2669–2676
